Study maps hidden infection risks for kids after cancer treatment
NCT ID NCT05622682
Summary
This study followed children and young adults for one year after they finished treatment for acute lymphoblastic leukemia (ALL) to understand how their immune systems recover. Researchers tracked how often participants got infections and measured their immunity to vaccine-preventable diseases like measles and chickenpox. The findings will help doctors decide if these patients need additional vaccine doses after cancer treatment to stay protected.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, PEDIATRIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
-
CHRISTUS Children's (Affiliate of Baylor College of Medicine)
San Antonio, Texas, 78207, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Helen DeVos Children's Hospital
Grand Rapids, Michigan, 49503, United States
-
Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee, 37232, United States
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
Conditions
Explore the condition pages connected to this study.